News

Pharmabiz12h
EMA committee recommends approval of AstraZeneca’s Imfinzi to treat adult patients with resectable muscle-invasive bladder cancer
EMA committee recommends approval of AstraZeneca’s Imfinzi to treat adult patients with resectable muscle-invasive bladder cancer: Cambridge, UK Tuesday, May 27, 2025, 15:00 Hrs ...
Pharmabiz14h
Quadria Capital closes oversubscribed US$ 1 billion Fund III to advance healthcare transformation across Asia
Quadria Capital closes oversubscribed US$ 1 billion Fund III to advance healthcare transformation across Asia: Our Bureau, Bengaluru Tuesday, May 27, 2025, 13:30 Hrs [IST] Quadria ...
Pharmabiz9h
European Commission grants orphan drug designation to Alligator Bioscience’s HLX22 to treat gastric cancer
European Commission grants orphan drug designation to Alligator Bioscience’s HLX22 to treat gastric cancer: Lund, Sweden Tuesday, May 27, 2025, 18:00 Hrs [IST] Alligator Bioscie ...
Pharmabiz10h
JCB Collaborates enters MoU with Noage International to expand advanced medical tourism programme in Japan for affluent Indonesians
JCB Collaborates enters MoU with Noage International to expand advanced medical tourism programme in Japan for affluent Indonesians: Tokyo Tuesday, May 27, 2025, 17:00 Hrs [IST] J ...
Pharmabiz13h
Lupin to present phase 1 data on LNP7457, a PRMT5 inhibitor at American Society of Clinical Oncology 2025
Lupin to present phase 1 data on LNP7457, a PRMT5 inhibitor at American Society of Clinical Oncology 2025: Our Bureau, Bengaluru Tuesday, May 27, 2025, 13:45 Hrs [IST] Global phar ...
Pharmabiz11h
GSK seeks Health Canada approval for depemokimab to treat of asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps
Mississauga, Ontario Tuesday, May 27, 2025, 16:00 Hrs [IST] ...
Pharmabiz11h
India’s rise to fourth largest economy will boost manufacturing and MedTech: AiMeD
India’s rise to fourth largest economy will boost manufacturing and MedTech: AiMeD: Our Bureau, New Delhi Tuesday, May 27, 2025, 16:10 Hrs [IST] In the wake of the latest announ ...
Pharmabiz14h
Crescita Therapeutics & Croma Pharma mutually terminates commercialization and development license agreement for Pliaglis
Crescita Therapeutics & Croma Pharma mutually terminates commercialization and development license agreement for Pliaglis: Laval, Quebec Tuesday, May 27, 2025, 13:00 Hrs [IST] Cre ...
Pharmabiz16h
Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM
Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM: San Francisco, US Tuesday, May 27, 2025, 11:00 Hrs [IST ...
Pharmabiz15h
EMA committee recommends marketing approval for SpringWorks’ mirdametinib to treat adult & paediatric patients with NF1-PN
EMA committee recommends marketing approval for SpringWorks’ mirdametinib to treat adult & paediatric patients with NF1-PN: Stamford, Connecticut Tuesday, May 27, 2025, 12:00 Hr ...
Pharmabiz13h
MedLern partners with OMNI Hospitals to enhance healthcare training across five branches
MedLern partners with OMNI Hospitals to enhance healthcare training across five branches: Our Bureau, Bengaluru Tuesday, May 27, 2025, 14:15 Hrs [IST] MedLern, a leading digital l ...
Pharmabiz17h
China NMPA grants breakthrough therapy designation to Abbisko Therapeutics’ irpagratinib to treat hepatocellular carcinoma
China NMPA grants breakthrough therapy designation to Abbisko Therapeutics’ irpagratinib to treat hepatocellular carcinoma: Shanghai Tuesday, May 27, 2025, 10:00 Hrs [IST] Abbis ...